Patents by Inventor Alain Le Pape

Alain Le Pape has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9439982
    Abstract: The invention relates to fluorescent derivatives of cyanines conjugated with a polyamine group, having formula (I), or a pharmaceutically acceptable salt thereof. The invention also relates to the method for preparing said derivatives, diagnostic compositions containing same and the use thereof as a diagnostic probe for the detection of cancer tumors, in particular in vivo.
    Type: Grant
    Filed: November 24, 2011
    Date of Patent: September 13, 2016
    Assignees: PIERRE FABRE MEDICAMENT, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
    Inventors: Yves Guminski, Thierry Imbert, Sabrina Pesnel, Arnaud Pillon, Alain Le Pape, Stephanie Lerondel
  • Publication number: 20130183247
    Abstract: The invention relates to fluorescent derivatives of cyanines conjugated with a polyamine group, having formula (I), or a pharmaceutically acceptable salt thereof. The invention also relates to the method for preparing said derivatives, diagnostic compositions containing same and the use thereof as a diagnostic probe for the detection of cancer tumours, in particular in vivo.
    Type: Application
    Filed: November 24, 2011
    Publication date: July 18, 2013
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), PIERRE FABRE MEDICAMENT
    Inventors: Yves Guminski, Thierry Imbert, Sabrina Pesnel, Arnaud Pillon, Alain Le Pape, Stephanie Lerondel
  • Publication number: 20130171067
    Abstract: The invention relates to a compound having formula (I), compositions containing same and preparation methods thereof. The invention also relates to a complex of the compound having formula (I) with technetium-99m and tricine, the use of this complex as a diagnostic probe, diagnostic compositions containing same and methods for preparing the complex and compositions containing same.
    Type: Application
    Filed: November 24, 2011
    Publication date: July 4, 2013
    Applicant: PIERRE FABRE MEDICAMENT
    Inventors: Yves Guminski, Thierry Imbert, Sabrina Pesnel, Nicolas Guilbaud, Alain Le Pape, Stéphanie Lerondel
  • Patent number: 5601799
    Abstract: The present invention relates to a D 25 polysaccharide compound whose lipid has been partially removed and to its derivatives, wherein at least 85% by weight, preferably 90% of the compound, exists in aqueous solution in monomeric form. The 30 kD molecular weight polysaccharide compound extracted from the membrane proteoglycan of the bacterium Klebsiella pneumoniae is mentioned in particular. The amount of palmitic fatty acids which is bound to it in esterified form does not exceed 0.01% by weight of the compound and the amount of palmitic fatty acids which is associated with it in the free form does not exceed 0.1% by weight of the compound.
    Type: Grant
    Filed: January 6, 1995
    Date of Patent: February 11, 1997
    Assignee: Pierre Fabre Medicament
    Inventors: Hans Binz, Lucien Dussourd D'Hinterland, Gerard Normier, Alain Le Pape, Michel Favaron, Souhail Delassan
  • Patent number: 5362474
    Abstract: The present invention relates to an aerosol composition containing a carrier agent capable of recognizing and binding to inflammatory and tumor foci mobilizing macrophages in their immediate environment, and an aerosol substrate, characterized in that the said carrier agent consists of a polysaccharide compound selected from the compound D 25, extracted from the membrane proteoglycans of the bacterium Klebsiella pneumoniae and having a molecular weight of 30.+-.0.10 Kd, and the compound oxidized D 25 in which the galactofuranoser residue (Gal.sub.f) of the linear polysaccharide chain of D 25 has been converted to arabinose, and their amide, ester or ether type derivatives, as well as their quaternary ammonium derivatives and salts, and also the derivatives obtained by grafting of phosphatides.
    Type: Grant
    Filed: July 8, 1992
    Date of Patent: November 8, 1994
    Assignee: Pierre Fabre Medicament
    Inventors: Lucien D. D'Hinterland, Alain Le Pape, Gerard Normier, Anne-Marie Pinel, Jacques Durand
  • Patent number: 4938947
    Abstract: The present invention relates to an aerosol composition for in vivo imaging or ex vivo diagnosis of tumors, which composition contains one or more soluble fragments of bacterial wall or cell peptidoglycan or equivalent synthetic compounds which are labelled with a radioactive, paramagnetic or fluorescent element and encapsulated in liposomes and a substrate which can be used for administration by aerosol.
    Type: Grant
    Filed: January 4, 1988
    Date of Patent: July 3, 1990
    Assignee: Centre National de la Recherche Scientifique (CNRS)
    Inventors: Yves-Claude Nicolau, Alain Le Pape, Rita Barot-Ciorbaru